120 Participants Needed

Time-Restricted Eating for Childhood Obesity

AV
YP
HP
Overseen ByHarvey Peralta
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Children's Hospital Los Angeles
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Time-Restricted Eating for Childhood Obesity?

Intermittent fasting, a form of time-restricted eating, has shown health benefits in various patient groups and healthy individuals due to metabolic and hormonal changes. This suggests potential benefits for children with obesity, although direct evidence in this specific group is not provided.12345

Is time-restricted eating safe for children with obesity?

Time-restricted eating (TRE) appears to be generally safe for humans, with studies showing it can lead to mild weight loss and improvements in blood pressure and insulin resistance. However, specific safety data for children is limited, and more research is needed to fully understand its effects on growth and eating behaviors in this age group.678910

How is time-restricted eating different from other treatments for childhood obesity?

Time-restricted eating (TRE) is unique because it focuses on limiting the hours during which food is consumed each day, rather than restricting specific foods or counting calories. This approach can be more flexible and less stigmatizing for children, as it avoids prolonged calorie restriction that might interfere with growth and development.67101112

What is the purpose of this trial?

Determine the effectiveness of how limiting the time you eat within an early or late eating window and fasting for remainder of the day will impact weight loss and body mass index (BMI).

Research Team

AV

Alaina P Vidmar, MD

Principal Investigator

Children's Hospital Los Angeles

Eligibility Criteria

This trial is for adolescents aged 12-21 with obesity, defined as having a BMI above the 95th percentile. They must be able to follow the study's schedule and eating/fasting times, which requires not currently being in other weight loss studies, no history of bariatric surgery or certain medical conditions like Prader-Willi Syndrome, brain tumors, diabetes, serious intellectual disability or eating disorders.

Inclusion Criteria

Participant must be willing and able to adhere to the assessments, visit schedules, and eating/fasting periods
Baseline eating window greater than 12 hours.
I am between 12 and 21 years old and have obesity.

Exclusion Criteria

I have had or almost had an eating disorder like anorexia, bulimia, or binge-eating.
My guardian believes I can't participate in the study assessments due to physical or mental reasons.
I have had weight loss surgery in the past.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are assigned to either early or late time-restricted eating for 24 weeks to assess effects on glycemic profiles, weight loss, and body composition

24 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Early Time Restricted Eating
  • Late Time Restricted Eating
Trial Overview The study tests two different time-restricted eating strategies for managing obesity in adolescents at risk for diabetes. One group will eat during an early window and fast afterwards; another will have a later eating window. The focus is on when they eat rather than what or how much.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Late Time Restricted EatingExperimental Treatment1 Intervention
late TRE (12:00 to 20:00 h)
Group II: Early Time Restricted EatingExperimental Treatment1 Intervention
early-day TRE (7:00 to 15:00 h)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Hospital Los Angeles

Lead Sponsor

Trials
257
Recruited
5,075,000+

Findings from Research

The study aims to evaluate the safety and feasibility of intermittent fasting in critically ill children in the PICU by comparing an overnight feeding interruption to continuous 24-hour nutrition, involving 140 participants over a 14-day period.
The primary outcome will assess differences in ketosis between the two feeding strategies, while secondary outcomes will include feeding intolerance and severe hypoglycemic events, providing insights into the potential clinical benefits of intermittent nutrition.
Continuous Versus Intermittent Nutrition in Pediatric Intensive Care Patients: Protocol for a Randomized Controlled Trial.Veldscholte, K., Cramer, ABG., de Jonge, RCJ., et al.[2022]
Early total enteral feeding (ETEF) in stable very low birth weight (VLBW) infants is safe and feasible, showing no significant increase in the risk of necrotizing enterocolitis (NEC) or feeding intolerance compared to slower feeding advancements.
ETEF is associated with a lower risk of late-onset sepsis and a reduced length of hospital stay by about 1.31 days, suggesting potential benefits for the health and recovery of these infants.
Early total enteral feeding in stable preterm infants: a systematic review and meta-analysis.Alshaikh, B., Dharel, D., Yusuf, K., et al.[2022]
In a randomized clinical trial involving 50 growth-restricted preterm infants, those who received early enteral feeding reached full feeding significantly faster and regained birth weight more quickly compared to those who were fed later.
Early feeding was associated with a lower incidence of neonatal sepsis, reduced feeding intolerance, shorter hospital stays, and better weight gain by day 16, indicating that it is a safe and beneficial practice for these vulnerable infants.
Early Versus Delayed Enteral Feeding for Achieving Full Feeding in Preterm Growth-Restricted Infants: A Randomized Clinical Trial.Ahmed, F., Dey, SK., Shahidullah, M., et al.[2020]

References

Continuous Versus Intermittent Nutrition in Pediatric Intensive Care Patients: Protocol for a Randomized Controlled Trial. [2022]
Early total enteral feeding in stable preterm infants: a systematic review and meta-analysis. [2022]
Early Versus Delayed Enteral Feeding for Achieving Full Feeding in Preterm Growth-Restricted Infants: A Randomized Clinical Trial. [2020]
Two-hourly versus 3-hourly feeding for very low birthweight infants: a randomised controlled trial. [2017]
Timing of enteral nutrition and parenteral nutrition in the PICU. [2023]
Acceptability of Time-Limited Eating in Pediatric Weight Management. [2023]
Time-Limited Eating in Pediatric Patients with Obesity: A Case Series. [2022]
Randomized controlled trial for time-restricted eating in overweight and obese young adults. [2022]
Current research: effect of time restricted eating on weight and cardiometabolic health. [2022]
Time-Restricted Feeding during Puberty Ameliorates Adiposity and Prevents Hepatic Steatosis in a Mouse Model of Childhood Obesity. [2021]
Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Time-Restricted Eating to Improve Cardiovascular Health. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security